EHC — Encompass Health Cashflow Statement
0.000.00%
Last trade - 00:00
- $7.93bn
- $11.23bn
- $4.80bn
- 95
- 36
- 97
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 446 | 369 | 517 | 366 | 463 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 111 | 47.8 | 32.2 | 98.8 | 59.7 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -180 | -7.3 | -118 | -30.4 | 50.3 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 635 | 705 | 716 | 706 | 851 |
Capital Expenditures | -404 | -408 | -551 | -584 | -583 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -253 | 0.7 | -115 | -42.9 | -19.7 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -657 | -408 | -666 | -627 | -603 |
Financing Cash Flow Items | -273 | -235 | -61.4 | 452 | -53.5 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 48.2 | -146 | -240 | -146 | -197 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 26.1 | 151 | -191 | -66.9 | 50.8 |